AbbVie | Pharmatell

Eyes on Pharma

Check-out What Intel Caught our Eye

Dec 1116 min read

Eyes on 3Q24 Financial Results

We've highlighted a few firms: Lilly, AbbVie, Pfizer, Novo Nordisk, BMS, Roche, Novartis, Merck, AstraZeneca, GSK, Viatris, Teva, and Amgen.

Nov 305 min read

Eyes On Alzheimer's, Epilepsy, Immunology, and Obesity

This week, we had eyes on data readouts, launch metrics, M&A, and more. Catch up with the news from Roche, AstraZeneca, Lundbeck, and AbbVie

Nov 15 min read

Eyes On October M&A activities, Approvals, and more

Last month, we had Eyes On some of the latest approvals, M&A and litigation. Read more about AbbVie, Genentech, Lundbeck, and GSK ...